Uncommon mutation in mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS)
暂无分享,去创建一个
[1] C. Reis,et al. Mitochondrial Encephalomyopathy With Lactic Acidosis and Strokelike Episodes Presenting Before 50 Years of Age: When a Stroke Is Not Just a Stroke. , 2016, JAMA neurology.
[2] R. Saneto,et al. Neuropsychiatric Features in Primary Mitochondrial Disease. , 2016, Neurologic clinics.
[3] C. Silvado,et al. When should MELAS (Mitochondrial myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes) be the diagnosis? , 2015, Arquivos de neuro-psiquiatria.
[4] Ying-xin Wang,et al. Progress in Diagnosing Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like Episodes , 2015, Chinese medical journal.
[5] Robert W. Taylor,et al. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease , 2015, Annals of neurology.
[6] B. Bornstein,et al. Leigh Syndrome and the Mitochondrial m.13513G>A Mutation , 2013, Journal of child neurology.
[7] Robert W. Taylor,et al. The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A>G mutation—implications for diagnosis and management , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[8] P. Chinnery,et al. Diagnosis and treatment of mitochondrial myopathies , 2011, Annals of medicine.
[9] M. Tarnopolsky,et al. The psychiatric presentation of mitochondrial disorders in adults. , 2012, The Journal of neuropsychiatry and clinical neurosciences.
[10] C. Santosh,et al. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: an important cause of stroke in young people , 2012, Postgraduate Medical Journal.
[11] C. V. van Karnebeek,et al. Expanding the clinical phenotype of the mitochondrial m.13513G>A mutation with the first report of a fatal neonatal presentation , 2011, Developmental medicine and child neurology.
[12] F. Scaglia. The role of mitochondrial dysfunction in psychiatric disease. , 2010, Developmental disabilities research reviews.
[13] S. Rahman,et al. Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases , 2009, Journal of Neurology, Neurosurgery & Psychiatry.
[14] Bruce H. Cohen,et al. Mitochondrial Disease in Autism Spectrum Disorder Patients: A Cohort Analysis , 2008, PloS one.
[15] W. Hwu,et al. Mutation of mitochondrial DNA G13513A presenting with Leigh syndrome, Wolff-Parkinson-White syndrome and cardiomyopathy. , 2008, Pediatrics and neonatology.
[16] J. Ganesh,et al. The G13513A mutation in the ND5 gene of mitochondrial DNA as a common cause of MELAS or Leigh syndrome: evidence from 12 cases. , 2008, Archives of neurology.
[17] B. Cohen,et al. Psychiatric Comorbidity in 36 Adults with Mitochondrial Cytopathies , 2007, CNS Spectrums.
[18] R. Rodenburg,et al. The mitochondrial 13513G>A mutation is most frequent in Leigh syndrome combined with reduced complex I activity, optic atrophy and/or Wolff–Parkinson–White , 2007, European Journal of Human Genetics.
[19] I. Nonaka,et al. Leigh syndrome caused by mitochondrial DNA G13513A mutation: frequency and clinical features in Japan , 2004, Journal of Human Genetics.
[20] Dominic Thyagarajan,et al. Low mutant load of mitochondrial DNA G13513A mutation can cause Leigh's disease , 2003, Annals of neurology.
[21] P. Bénit,et al. The mitochondrial DNA G13513A MELAS mutation in the NADH dehydrogenase 5 gene is a frequent cause of Leigh-like syndrome with isolated complex I deficiency , 2003, Journal of medical genetics.
[22] S. Dimauro,et al. MELAS: An original case and clinical criteria for diagnosis , 1992, Neuromuscular Disorders.